Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study.
about
Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.mRNA levels of low-density lipoprotein receptors are overexpressed in the foci of deep bowel endometriosis.A critical review of lipid-based nanoparticles for taxane delivery.Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing miceTreatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles.Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer.Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancerBreakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Advances in non-invasive drug delivery for atherosclerotic heart disease.Lipid-Drug Conjugate for Enhancing Drug Delivery.Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model.Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake.Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.Bottom up design of nanoparticles for anti-cancer diapeutics: "put the drug in the cancer's food".Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report.Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents.
P2860
Q35488032-D086F64E-2288-4E8E-A51B-3033811E1D96Q36227053-5B9E4C97-D46F-4CAF-95CF-90C3BDC68B3CQ36360764-DF23FC20-34DB-47A7-BC5B-96242A721E86Q36518939-55CCF59F-0FD6-420B-9F66-9D79071467E8Q36677466-07D24EE6-5A54-46DC-AB1B-277782807B0CQ37156203-E42CCAFA-C8D0-4467-A634-C8500D1851EEQ37214592-11EBDC98-971A-483C-9914-F6B4B01ABEAFQ37371188-7129AB0E-C7DF-4044-9D28-CA8721E30BE8Q37603577-014F589B-FC50-4088-9E0A-C3499D37A91CQ38168361-B9488D24-17D7-41DA-ADDA-7271FB9E799AQ38317205-D854BB20-5747-40A4-AA0E-24A684500882Q39083391-84E4B69F-75F4-4D28-B055-59D8D492E0A0Q41452570-3900CBCB-3C51-42DC-B8DE-E6DE5F88BA27Q42081306-E433B4CA-9315-4312-B8CB-82BCE829F220Q48012324-D4B8D5D2-C37F-4565-B1B4-53645AD64491Q51159201-5E34B736-ADCC-46D8-9513-CE69D565FC9EQ51731306-6180E463-B3E4-4047-96CC-314F249E7385Q51743444-E8EFBD15-212C-4F3C-A276-C62FFC7FCCFBQ53598744-777D1BF2-605C-4429-8CBC-F92759739107
P2860
Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@en
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@nl
type
label
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@en
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@nl
prefLabel
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@en
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@nl
P2093
P1476
Use of cholesterol-rich nanopa ...... ke and a pilot clinical study.
@en
P2093
Claudete J Valduga
Débora G Rodrigues
Luís A Pires
Roberto Hegg
Sílvia R Graziani
P2860
P2888
P304
P356
10.1007/S00280-008-0738-2
P577
2008-03-26T00:00:00Z